API
< Back to all clusters
[HEALTH] · Bulgaria, France · 4 sources

started · updated

Bulgaria expects arrival of 40,000 Vaxigrip doses for pharmacies

Bulgaria is set to receive 40,000 doses of the Vaxigrip influenza vaccine, which will be distributed to pharmacies for over-the-counter sale in the coming days. Suix Biopharma, the local representative for the French manufacturer, stated that the doses must undergo quality checks before reaching wholesale warehouses and retail pharmacies.

An additional 30,000 doses are expected by the end of November, though these will require packaging adaptation for the Bulgarian market. This brings the total expected for the free market in November to 70,000 doses. Meanwhile, the Influvac vaccine remains reserved exclusively for national immunization programs targeting children and seniors.

Delays in vaccine availability for the free market were attributed to uncertain planning and a lack of clear data. Experts noted that manufacturers often prioritize markets with more stable consumption patterns and better planning. To improve access, proposed legislative changes may allow pharmacists to administer vaccines directly, similar to practices in Greece.

Entities

Bulgaria · France · Suix Biopharma · Vaxigrip · World Health Organization